Drug intelligence / Profile preview

bacteriophages

Development stage
Phase 3
Lead developer
George Eliava Institute of Bacteriophage, Microbiology and Virology
Administration
Topical, Oral, Intravenous, Inhalation, Ophthalmic, Otic, Intravesical, Rectal
01

Overview

Bacteriophages are viruses that specifically target and infect bacteria. They attach to bacterial cells, inject their genome, and interfere with the bacteria's ability to function, halting bacterial infections. The bacteria become unable to reproduce and instead produce additional phages. Phages are highly selective in the bacterial strains they target, making them an attractive alternative to antibiotics, especially for treating multi-drug resistant infections. Their specificity allows them to kill pathogenic bacteria without affecting beneficial bacteria in the microbiome, reducing side effects and the risk of opportunistic infections. Bacteriophages have been used therapeutically since the early 20th century but were largely replaced by antibiotics after World War II in most parts of the world. However, due to increasing antibiotic resistance, interest in phage therapy has been revived in recent years.

Other names
phagebacterial virus噬菌体

Beyond the preview

Go deeper on bacteriophages.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bacteriophages.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call